Aspen Pharmacare Holdings Ltd. ADR logo

Aspen Pharmacare Holdings Ltd. ADR (APNHY)

Market Closed
4 Dec, 20:00
OTC PINK OTC PINK
$
5. 55
+0.17
+3.16%
$
2.99B Market Cap
20.07 P/E Ratio
0.48% Div Yield
8,700 Volume
0 Eps
$ 5.38
Previous Close
Day Range
5.49 5.64
Year Range
5.24 10.14
Want to track APNHY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 87 days

Summary

APNHY closed today higher at $5.55, an increase of 3.16% from yesterday's close, completing a monthly increase of 3.16% or $0.17. Over the past 12 months, APNHY stock lost -32.81%.
APNHY pays dividends to its shareholders, with the most recent payment made on Oct 08, 2024. The next estimated payment will be in 1 month ago on Oct 08, 2025 for a total of $0.2.
The last earnings report, released on 10 hours ago, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.61%, based on the last three reports. The next scheduled earnings report is due on Mar 02, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

APNHY Chart

Aspen Pharmacare Holdings Ltd. ADR (APNHY) FAQ

What is the stock price today?

The current price is $5.55.

On which exchange is it traded?

Aspen Pharmacare Holdings Ltd. ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is APNHY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.48%.

What is its market cap?

As of today, the market cap is 2.99B.

When is the next earnings date?

The next earnings report will release on Mar 02, 2026.

Has Aspen Pharmacare Holdings Ltd. ADR ever had a stock split?

No, there has never been a stock split.

Aspen Pharmacare Holdings Ltd. ADR Profile

- Industry
- Sector
Mr. Stephen Bradley Saad BCom, CA(SA) CEO
OTC PINK Exchange
04530Y106 CUSIP
ZA Country
8,867 Employees
20 Sep 2024 Last Dividend
18 Jul 2012 Last Split
- IPO Date

Overview

Aspen Pharmacare Holdings Limited, a pioneering force in the pharmaceutical industry, orchestrates the manufacture and global distribution of specialty and branded pharmaceutical products through its extensive network of subsidiaries. It distinctly segments its operations into Commercial Pharmaceuticals and Manufacturing. Originally established in 1850 and currently with its headquarters nestled in Durban, South Africa, Aspen Pharmacare has grown to play a pivotal role in the global pharmaceutical landscape, addressing a wide range of healthcare needs.

Products and Services

Aspen Pharmacare’s product portfolio spans across various therapeutic areas, showcasing a diversified range of pharmaceutical solutions:

  • Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine: These brand names represent Aspen’s foray into anesthetics, including general, local, and regional anesthesia options, offering solutions for surgical pain management and procedural sedation.
  • Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin: These brands cater to a variety of medical conditions. Circadin is utilized as a sleeping aid, addressing insomnias and sleep disorders. Eltroxin serves as a thyroid hormone replacement therapy, essential for managing hypothyroidism. Foxair offers respiratory relief for conditions like asthma through its airway dilating properties, while Imuran, an immunosuppressant, is crucial for patients undergoing organ transplants or suffering from autoimmune diseases. Maltofer provides an iron supplement solution, combatting iron deficiency anemia. Mybulen, an analgesic anti-inflammatory, assists in managing pain and inflammation, whereas Ovestin offers hormone replacement therapy, specifically tailored for menopausal symptoms.
  • Active Pharmaceutical Ingredients (APIs) and Finished Dose Form Products: Beyond its bespoke brand offerings, Aspen is also instrumental in the production and distribution of active pharmaceutical ingredients, crucial for the pharmaceutical manufacturing process. It extends its expertise to finished dose form products, ensuring quality pharmaceuticals are accessible globally.

Contact Information

Address: Aspen Place
Phone: 27 31 580 8600